AI Verdict
AMGN has stronger fundamentals based on our AI analysis.
AMGN vs CVS Fundamental Comparison
| Metric | AMGN | CVS |
|---|---|---|
| Revenue | $36.8B | $402.1B |
| Net Income | $7.7B | $1.8B |
| Net Margin | 21.0% | 0.4% |
| ROE | 89.1% | 2.4% |
| ROA | 8.5% | 0.7% |
| Current Ratio | 1.14x | 0.84x |
| Debt/Equity | 6.31x | 0.85x |
| EPS | $14.23 | $1.39 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
AMGN vs CVS: Frequently Asked Questions
Is AMGN or CVS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMGN has stronger fundamentals. AMGN is rated BUY (84% confidence) while CVS is rated HOLD (70% confidence). This is not investment advice.
How does AMGN compare to CVS fundamentally?
AMGEN INC has ROE of 89.1% vs CVS HEALTH Corp's 2.4%. Net margins are 21.0% vs 0.4% respectively.
Which stock pays higher dividends, AMGN or CVS?
AMGN has a dividend yield of N/A or no dividend while CVS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in AMGN or CVS for long term?
For long-term investing, consider that AMGN has BUY rating with 84% confidence, while CVS has HOLD rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about AMGN vs CVS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For AMGN vs CVS, the AI consensus favors AMGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.